XtalPi hands Pierre Fabre a molecule factory for stubborn cancer targets
French drugmaker Pierre Fabre will lean on XtalPi's AI and robotics platform to chase hard-to-drug cancer targets it has struggled…
Trending Now
Robinhood Ventures Fund II brings retail capital to healthcare AI
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
Singapore clinics let an AI watch for referrals nobody ever sent
A safety net built from consultation notes caught missed specialist referrals at…
An AI team of agents grades immunotherapy side effects
A Brigham and Dana-Farber system of cooperating language models caught immune-related adverse…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Novo Nordisk puts Claude Science to work on stubborn research problems
The Danish drugmaker will test Anthropic's Claude Science models against research questions it has so…
AI-Powered Skin Cancer Tool DERM Rolls Out in Barking & Dagenham to Cut Wait Times and Boost Early Detection
Skin Analytics and Together First are bringing DERM, a groundbreaking autonomous AI skin cancer assessment…
Study finds almost no FDA-cleared AI devices tested on outcomes
A PLOS Digital Health study finds only three of 1,357 FDA-cleared AI devices were ever…
A five-person Korean startup bets on agents that draft clinical notes
GaiaBT is wiring AI drug design to external lab experiments, aiming to predict which patients…
David Baker’s lab with Nvidia releases model that reasons about molecules
RFD4-Proteina pairs the Institute for Protein Design's RosettaFold Diffusion line with Nvidia's BioNeMo platform, lifting…
New Zealand health system partners with NHS for AI scribe rollout
Te Whatu Ora partners with UCLPartners to gain evidence and confidence for AI scribe deployment…
Ono taps Aitia’s causal AI twins to unmask neurology drug targets
Ono Pharma will use Aitia's causal AI digital twins to find new drug targets in…
Commure cuts referral payouts after STAT probe
The $7B AI health company cut payments to customers who referred new business days after…